Cargando…
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease
The biomarkers of Parkinson’s disease (PD) remain to be investigated. This work aimed to identify blood biomarkers for PD using targeted metabolomics analysis. We quantified the plasma levels of 255 metabolites in 92 PD patients and 60 healthy controls (HC). PD patients were sub-grouped into early (...
Autores principales: | Chang, Kuo-Hsuan, Cheng, Mei-Ling, Tang, Hsiang-Yu, Huang, Cheng-Yu, Wu, Hsiu-Chuan, Chen, Chiung-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834036/ https://www.ncbi.nlm.nih.gov/pubmed/35159203 http://dx.doi.org/10.3390/cells11030395 |
Ejemplares similares
-
Alterations of Plasma Galectin-3 and C3 Levels in Patients with Parkinson’s Disease
por: Wu, Hsiu-Chuan, et al.
Publicado: (2021) -
Quantitative Analyses and Validation of Phospholipids and Sphingolipids in Ischemic Rat Brains
por: Huang, Chiung-Yin, et al.
Publicado: (2022) -
Biomarker of Neuroinflammation in Parkinson’s Disease
por: Liu, Tsai-Wei, et al.
Publicado: (2022) -
Regulation of Necroptosis by Phospholipids and Sphingolipids
por: Zhang, Xuewei, et al.
Publicado: (2020) -
Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2023)